S U M M A R Y Immunohistochemistry to active caspase-3, recently recommended for apoptosis detection, is inappropriate to detect apoptosis involving caspase-7. Cleavage of poly-ADPribose polymerase 1 (PARP-1), a major substrate of both caspases, is a valuable marker of apoptosis. Apoptosis evaluation induced in vitro either by paclitaxel or by photodynamic treatment (PDT) with Foscan in HT29 or KB monolayer cells and HT29 spheroids yielded a close percentage of labeled cells whatever the antibody used, whereas in control specimens, cleaved PARP (c-PARP) immunostaining failed to detect apoptosis as efficiently as active caspase-3 or -7 immunostaining. Studies in MDA-MB231 monolayer cells and HT29 xenografts either subjected or not subjected to Foscan-PDT resulted in a significant higher number of active caspase-3-labeled cells, although immunofluorescence analysis showed c-PARP and active caspase-3 perfectly colocalized in tumors. A restricted expression of c-PARP was obvious in the greater part of caspase-3 expressing cells from control tumor, whereas photosensitized tumors showed a higher number of cells expressing large fluorescent spots from both active caspase-3 and c-PARP. These results support the assumption that c-PARP expression was dependent on treatment-induced apoptosis. The absence of caspase-7 activation in some caspase-3-expressing cells undergoing Foscan-PDT shows the relevance of using antibodies that can discriminate caspase-dependent apoptotic pathways. (J Histochem Cytochem 57:289-300, 2009) K E Y W O R D S apoptosis caspase-3 caspase-7 poly-ADP-ribose polymerase THE MOLECULAR and biochemical events of apoptotic cell death have been extensively studied (reviewed in Jin and El-Deiry 2005) . Many anticancer drugs induce apoptosis by molecular mechanisms mediated through mitochondrial dysfunction (Green and Kroemer 2004) . Release of cytochrome c from the internal part of the mitochondrial membrane into the cytosol results in the activation of caspase cascades, in particular caspase-9, -3, -6, and -7. Because caspase-3 is the main executioner of apoptosis, IHC to the active form of caspase-3 (active casp-3) has been run to check apoptosis in paraffin sections from various tissue (Gown and Willingham 2002; Duan et al. 2003; Resendes et al. 2004; Jakob et al. 2008 ) and has been recommended in clinical trials as a biomarker of photodynamic treatment (PDT) activity in vivo (Miller et al. 2007 ). However, it is important to note that apoptosis may also occur through an activation of other executioner caspases such as caspase-7 that could be activated through a mechanism independent of the mitochondrial pathway (Davidson et al. 2005; Pyrko et al. 2007) . Moreover, caspase-7 could partially substitute caspase-3 in caspase-3-deficient cells (Mooney et al. 2002; Lakhani et al. 2006) . Many protein targets of active caspases are biologically important apoptotic indicators of morphological and biochemical changes associated with apoptosis (Degterev et al. 2003) . One of the essential substrates cleaved by both caspase-3 and -7 is poly-ADP-ribose polymerase (PARP), an abundant DNA-binding enzyme that detects and signals DNA strand breaks (Decker and Muller 2002) .
The presence of cleaved PARP-1 is one of the most used diagnostic tools for the detection of apoptosis in many cell types. The cleavage of PARP-1 into two fragments of 89 and 24 kDa has been considered indicative of functional caspase activation (Koh et al. 2005) . However, in sections from ethanol-fixed tissues, specific antibody to cleaved PARP-1 (c-PARP) was unsuccessfully tested (Holubec et al. 2005) .
In this study, we assessed apoptosis by using polyclonal antibodies to active caspase-3, active caspase-7, and c-PARP to give a precise insight into the relevance of each marker for the IHC detection of apoptosis. Moreover, the accuracy of antibodies to active caspase-7 and c-PARP to detect apoptosis in histopathology has never been reported in formaldehyde-fixed tissues. Apoptosis was induced in vitro by paclitaxel (McGrogan et al. 2008) or PDT with Foscan (Marchal et al. 2005) in monolayer HT29, KB, and MDA-MB231 carcinoma cell lines or spheroids growing HT29 cells. For the in vivo experiments, we used xenografted HT29 tumors in nude mice that were subjected to Foscan-PDT.
Materials and Methods
Monolayer Cell Cultures HT29 is a human colon adenocarcinoma cell line, MDA-MB231 is a human mammary adenocarcinoma cell line, and KB is a human cell line related to HeLa cells. These cells were obtained from the American Type Culture Collection (Rockville, MD) and were grown in RPMI-1640 medium (Invitrogen; Cergy-Pontoise, France) without phenol red and glutamine, supplemented with 10% heat-inactivated FCS (PAN Biotech; Aidenbach, Germany), 1% penicillin (10,000 UI/ml)streptomycin (10,000 mg/ml), and 1% 200 mM glutamine (Invitrogen). Cells were kept at 37C in a 95% air/5% CO 2 humidified atmosphere. They were subcultured every 7 days using 2.5% trypsin with 1 mM EDTA (Invitrogen).
Spheroid Cell Culture
Multicell spheroids of the HT29 cell line were initiated as previously described (Marchal et al. 2005) . Briefly, 5 3 10 4 HT29 cells were seeded into 75-cm 2 flasks previously coated with 1% L-agarose. After 3 days, aggregates were transferred to 250-ml spinner flasks (Integra Biosciences; Chur, Switzerland) containing 150 ml culture medium. The flasks were placed on magnetic plates (Integra Biosciences) at 75 rpm in 5% CO 2 and 37C humidified atmosphere for 15 days. Spheroids reaching ?500 mm in diameter were used in experiments.
Xenografted Tumors
Studies were performed using female athymic Swiss Foxn 1nu /Foxn 1nu mice (Harlan; Gannat, France). All ani-mal experiments were carried out in compliance with the French Animal Scientific Procedures Act (April 1988) . Mice were housed in plastic cages under standard conditions (25C, 50% relative humidity, 12-hr light/dark cycle) and provided with food and water ad libitum. Procedure to induce HT29 tumors in nude mice was performed as previously described (Coutier et al. 2002) . Briefly, 0.1 ml of 8 3 10 7 HT29 cells/ml in 5% glucose solution was inoculated subcutaneously into the right hind foot. The mice were treated 15 days later when the tumors reached 5 mm in diameter. Three control tumors and seven treated tumors were sampled.
For each treatment (paclitaxel and photodynamic), three experiments were performed on cell lines and cell spheroids. Induction of apoptosis in cell lines, spheroids, and tumor transplants was carried out according to the following procedure.
Paclitaxel Treatment of Monolayers and Spheroids
Monolayer Cells. For each cell line, 3 3 10 4 cells/ml were seeded into 75-cm 2 flasks. Forty-eight hours after seeding, paclitaxel (Taxol; Sigma-Aldrich, Saint-Quentin Fallavier, France), dissolved in 95% ethanol (100 mM), was added to the culture medium at a final concentration of 0.1 mM. Treatment was carried out for 48 hr. Control cells were treated with 95% ethanol alone (dilution, 1:1000 v/v).
HT29 Spheroids. Approximately 80 spheroids were collected and seeded in 2 ml supplemented medium containing 0.1 mM paclitaxel for 48 hr. Control spheroids were incubated with supplemented medium containing only ethanol (dilution, 1:1000 v/v).
Photodynamic Treatment
Drug Preparation and Administration. Foscan [metatetra(hydroxyphenyl)chlorine] was kindly supplied by Biolitec (Jena, Germany). Foscan stock solution was prepared in methanol. Further dilutions of Foscan were performed in RPMI-1640 supplemented with FCS. Injection in animals was performed with a solution of Foscan diluted in a mixture of ethanol, polyethylene glycol, and water (2:3:5) as recommended by the manufacturer. Mice were injected in the tail vein with 0.3 mg/kg body weight at 24 hr before light exposure.
Monolayer Cells. Four days before treatment, 3 3 10 4 cells/ml of each cell line were seeded in 60-mmdiameter Petri dishes. Logarithmically growing cells were incubated with 1 mg/ml (1.45 mM) Foscan solution in RPMI supplemented with 2% FCS for 24 hr. After two washes, RPMI supplemented with 10% FCS was added, and cells were irradiated with a 650-nm laser diode at a fluence of 0.03 J/cm 2 delivered at a fluence rate of 1.92 mW/cm 2 . Control cells were incubated with Foscan and were not subjected to irra-diation (drug, no light). Twenty-four hours after PDT, cells were collected by trypsinization, washed, and fixed in 4% formaldehyde (pH 7.4).
HT29 Spheroids. HT29 spheroids were treated according to the method previously published (Marchal et al. 2005) . Briefly, after a 24-hr incubation with 4.5 mM Foscan RPMI supplemented with 10% FCS, spheroids were irradiated with a 650-nm laser diode at 5 J/cm 2 delivered at a fluence rate of 10 mW/cm 2 . Control spheroids were exposed to Foscan without illumination (drug, no light).
HT29 Xenografted Tumors. Twenty-four hours after Foscan IV injection, tumors were irradiated with a 650-nm diode laser at a fluence of 10 J/cm 2 delivered at a fluence rate of 30 mW/cm 2 . Control tumors were subjected to Foscan injection without irradiation (drug, no light). Twenty-four hours after PDT, the mice were sacrificed by anesthetic overdose, and the grafts were surgically removed and sectioned in 3-mm-thick slices before being processed.
Sample Collections and Fixation
Twenty-four hours after treatments, monolayer culture cells, spheroids, and tumor samples were fixed in 4% (m/v) formaldehyde (pH 7.4) for 16 hr. Tumors and pellets of monolayer culture cells and spheroids were routinely processed and embedded in paraffin. Paraffin blocks were used to generate 5-mm-thick hematoxylin and eosin-stained sections. Additional slices of transplants were also snap-frozen in isopentane precooled in liquid nitrogen. For each sample of monolayer cells, ultrastructural control was performed.
Transmission Electron Microscope
Cells were fixed overnight at 4C in 3% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) and transferred to 0.1 M phosphate buffer (pH 7.2). The cells were postfixed in 1% osmium tetroxide in S-collidine, dehydrated in graded ethanols, transferred to propylene oxide, and embedded in Epon 812. Semithin sections were stained with 1% methylene blue. The sample was further sectioned into ultrathin slices (75 nm), contrasted with uranyl acetate and lead citrate and observed on a transmission electron microscope (CM10; Philips, Eindhoven, The Netherlands).
c-PARP and Active Caspase-3 and-7 Immunolabeling IHC detection of apoptosis-related proteins was carried out on 5-mm-thick deparaffinized sections. Before IHC, sections were subjected to heat-induced epitope retrieval by incubation in a 0.01 M sodium citrate solution (pH 6) at 120C for 10 min, followed by a 2-hr cool-down. Primary antibodies were diluted in the following buffer: 0.1 M PBS, 0.3% (m/v) BSA, 0.1% (m/v) sodium azide, 0.06% (m/v) n-ethylmaleimide, and 20% (v/v) glycerol (PAB). Active caspase-3 was detected with a species-unspecific rabbit polyclonal antibody (1:1000 diluted; BD Biosciences, Le Pont-de-Claix, France) that specifically recognize the large fragment (17 kDa) of the active protein but not full-length caspase-3. The large fragment of active caspase-7 (20 kDa) was targeted by a species-unspecific rabbit polyclonal antibody (1:50 diluted) provided by Cell Signaling (Danvers, MA). For c-PARP IHC, sections were incubated in a solution of a rabbit polyclonal antibody (1/25 diluted; Cell Signaling, Danvers, MA). This species-specific antibody detects endogenous levels of the large fragment (89 kDa) of human PARP-1 resulting from cleavage at aspartic acid 214 but does not recognize full-length PARP-1 or other PARP isoforms. All antibodies applied in this study were previously used in Western blot analysis with satisfying results (Marchal et al. 2005 (Marchal et al. ,2007 . Primary antibodies were applied for 16 hr at 4C. The sections were washed in two changes of PBST (0.1 M phosphate buffer, pH 7.4, 0.1% (v/v) Tween 20) over 10 min and incubated with biotinylated goat anti-rabbit antibody (Dakocytomation; Trappes, France) diluted 1:200 for 1 hr at room temperature. After two PBST washes (for 10 min each), endogenous peroxidase activity was blocked by a 10-min incubation in a 6% hydrogen peroxide solution in distilled water. The slides were washed two times in PBST (for 5 min each time) and incubated in streptavidin-peroxidase (Dakocytomation) diluted 1:150 in PBST for 1 hr at room temperature. After two PBST washes of 5 min, bound peroxidase was identified using the Novared TR system (Abcys; Paris, France). Nuclear counterstaining was performed with 1/2-diluted Harris hematoxylin. Each assay was controlled negatively by processing sections in the absence of primary antibody. Good immunostaining data (i.e., low background staining and good precision) were obtained with three antibodies. False-positive cells were only observed in tissue sections of tumor transplants where endogenous biotin was detected by the streptavidin-biotin system of visualization. However, it was easy to distinguish between positive, negative, and false-positive cells. Tumor cells were never artifactually stained, and false-positive staining was limited to mastocytes in mouse connective tissue around the tumors and in sebaceous glands when present.
Determination of Apoptotic Indices
The number of apoptotic cells present in a section expressed as a fraction of the total number of cells, the so-called apoptotic index, measures an apoptotic state. For the purpose of this study, an activated caspase-3 labeling apoptotic index, an activated caspase-7 labeling apoptotic index, and a c-PARP labeling apoptotic index were calculated. The number of labeled cells in immunostained sections were counted relative to 2000 cells in the case of cell pellets. In sections of spheroids, at least three spheroids each composed of .300 non-necrotic cells were considered for each treatment condition. Because the antibody to c-PARP was human specific and did not visualize mouse stromal apoptotic cells, whereas the antisera to active caspase-3 and active caspase-7 stained apoptotic cells in both the stroma and the tumor cell compartment, the apoptotic indices in transplants were calculated as the number of apoptotic cells per total number of epithelial tumor cells. These indices were established by counting at least 2000 cells in fields distant from necrotic areas.
Colocalization Studies
Simultaneous visualization of active caspase-3 and either active caspase-7 or c-PARP in the same section was carried out in 5-mm-thick frozen sections of two xenografted tumors (one control and one treated). This was achieved by the sequential use of two indirect fluorescence methods whose specificity was previously checked. Active caspase-3 was stained by the first sequence and either active caspase-7 or c-PARP by the second one. Briefly, frozen sections were first fixed with 30% v/v polyethylene glycol in 95C ethanol for 10 min. They were then dried at room temperature for 15 min, washed in absolute ethanol, and rehydrated in PBST for 5 min. They were incubated in a solution of the anti-active caspase-3 rabbit antiserum (1/1000 dilution in PAB for 3 hr at room temperature). The sections were washed twice with PBST for 10 min and incubated with 1:200 biotinylated goat anti-rabbit antibody (Dakocytomation) for 1 hr at room temperature. After two PBST washes (for 10 min each), the sections were incubated in a 1:8000 Streptavidin-FluoProbe SR 101 (Interchim; Montluçon, France) in the dark at room temperature. After two PBST washes (for 5 min each), the sections were mounted in a fluorescent-free aqueous mountant glycerol/PBS (9/1, v/v). Image acquisition was immediately carried out with a fluorescent micro-scope (Axiophot II; Zeiss, Jena, Germany) equipped with a motorized XY stage and a cooled AxioCam HRc CCD camera (Zeiss) controlled by the Axiovision 4.4 digital image processing software. The Mark and Find module of this software was used to record the various positions photographed on the slides. Thereafter, the coverslips were removed, and the sections were soaked in 0.1 N HCl for 20 min to eliminate the tissuebound antibodies. After two PBST washes (for 5 min each), the second immunostaining sequence was carried out following the steps used in the first sequence. The antisera to active caspase-7 and c-PARP were respectively applied at a 1:50 and 1:25 dilution, and in the third step, Streptavidin Fluo Probe Alexa 488 (Interchim; Montluçon, France), diluted 1:4000, was used in place of Streptavidin-FluoProbe SR 101. The Mark and Find module was used to relocate the fields previously recorded, which were again photographed at the same magnification. The images of the same fields recorded under the two fluorescent modalities were merged using Axiovision software. Several controls were performed. First, the absence of cross-reactivity caused by residual antibodies of the first step was checked by omitting the second primary antibody of the double immunostaining method. Second, the absence of the deleterious effect of HCl on the second antibody signal was verified.
Statistical Analysis
Mann-Whitney's U-test was used to determine the statistical significance, with a limit set to p,0.05 using Staview 5.0 software.
Results

Apoptosis and Apoptosis-related Protein Assessment in Monolayer Cell Pellets
Morphological and IHC aspect of apoptosis was studied in three monolayer cell lines after their pretreat- ment with paclitaxel, an apoptosis inducer in many cell lines. Apoptosis was first recorded by morphological study on hematoxylin-eosin-safran-stained tissue sections ( Figure 1A) . Specific morphological changes indicative of apoptosis were identified in HT29 and KB cells but not in MDA cells (thin arrows). All cell lines, however, showed numerous cells with mitotic nuclei as a consequence of paclitaxel cytostatic treatment (thick arrows). The antibodies specific for active caspases-3 and -7 ( Figures 1B and 1C) selectively stained the cytoplasm of cells (thin arrows), whose nuclear morphology was consistent with apoptosis, along with the cytoplasm of morphologically healthy-looking cells, thus suggesting that these antibodies recognized activated protein at the early stage of apoptosis. Active caspase-3, opposite to caspase-7, was also occasionally detected in nuclei (thick arrows), thus featuring a translocation of the protein to the nucleus ( Figure 1B) . In apoptotic cells, whose nuclei were still not fragmented, c-PARP staining was limited to nuclear chromatin ( Figure 1D , thick arrows) and was distributed rather uniformly and diffusely over the whole nuclear area. Apoptotic bodies were clearly stained by all three markers.
After Foscan-PDT, a similar aspect in stained cells detected either by active caspase-3, active caspase-7, or c-PARP antibodies was obtained in HT29 and KB compared with paclitaxel treatment (data not shown). In MDA-MB231cells, typical apoptotic features including specific chromatin distribution and cytoplasm densification were observed both in HES (Figure 2A ) and ultrastructural examinations ( Figure 2B ). The chromatin was predominantly arranged as a circumferential layer of heterochromatin, whereas the central chromatin had a dispersed granula rand speckled appearance. An increase in electron density was observed in the cytosol ( Figure 2B ).
Similar ultrastructural modifications were observed in other cells treated by PDT along with HT 29 and KB cells after paclitaxel treatment (data not shown).
The apoptotic indices (AIs) obtained from all three markers in HT29, KB, and MDA-MB231 cell lines are shown in Figure 3 . Overall, ,4% of the cells were detected by the three markers in controls. We noticed that the number of cells labeled with the antibody to c-PARP gave statistically significant lower results compared with other markers. Irrespective of cell lines, mean AIs in control were 0.47 6 0.2% for c-PARP, 1.28 6 1.03% for active caspase-3 (p 5 0.02), and 1.19 6 0.71% for active caspase-7 (p 5 0.008). Similarly, paclitaxel-treated MDA-MB231 cells showed significantly less c-PARP-labeled cells (0.68 6 0.30%) than active caspase-3 (1.72 6 0.28%)-or active caspase-7 (1.79 6 0.46%)-labeled cells (p,0.05). In paclitaxel-treated HT29 and KB cells, c-PARP labeling (22.7 6 15.0% and 15.4 6 5.4%, respectively) and active caspase-7 labeling (23.8 6 19.8 and 14.3 6 3.5%, respectively) gave close AIs, whereas active caspase-3 labeling yielded slightly but not significantly greater AIs (30.2 6 7.6% and 17.8 6 5.2%, respectively). In Foscan-photosensitized cells, IHC analysis to active caspase-3, caspase-7, or c-PARP did not result in a statistically significant difference in HT29 (67.1 6 0.8%, 58.8 6 18.2%, and 68.2 6 4.7%, respectively) or KB cells (77.3 6 8.2%, 65.0 6 11.5%, and 59.6 6 13.7%, respectively). In MDA-MB231 cells, active caspase-3 clearly provided greater AI (57.0 6 2.1%) than either active caspase-7 (38.9 6 3.8%) or c-PARP (32.9 6 5.5%) labeling (p,0.05).
Apoptosis-related Protein Assessment in Spheroids
IHC to active caspase-3, active caspase-7, and c-PARP was applied to 29 spheroids subjected to different treatment protocols. Figure 4 shows the distribution of cells detected by the antibodies to active caspase-3, active caspase-7, and c-PARP in control spheroids (Figures 4A, 4B , and 4C, respectively) and in spheroids subjected to Foscan-PDT ( Figures 4D, 4E , and 4F, respectively). Control spheroids showed a few labeled cells around the necrotic core as clearly shown in the spheroids immunostained with either antiactive caspase-3 ( Figure 4A ) or anti-c-PARP antibody ( Figure 4C) . In Foscan-photosensitized spheroids (Figures 4D-4F ), the number of labeled cells increased in the area between the outer rim and the necrotic core. In addition, we noted a loss of cell cohesion. Distribution pattern of staining was the same irrespective of the technique used. AIs determined from non-necrotic cells of untreated or treated either by paclitaxel or Foscan-PDT spheroids are presented in Table 1 . In control spheroids, from 9.1% to 17.3% labeled cells were counted according to the method applied, with the lowest value for c-PARP (9.1 6 2.3%). The highest and identical scores were obtained with active caspase-3 (17.4 6 3.0%) and active caspase-7 (17.0 6 4.4%) labeling and were found sig- 
Apoptosis-related Protein Assessment in HT29 Subcutaneous Xenografts
The density of apoptotic cells was assessed in three control tumors and in seven xenografts 24 hr after Foscan-PDT ( Figure 5) . Variability in the level of apoptosis was patent. Overall, the extent of apoptosis detected with c-PARP in control tumors was significantly lower (0.2 6 0.2%) than active caspase-3 (1.4 6 1.2%) or active caspase-7 (1.4 6 0.7%) immunostaining (p,0.05). In Foscan-photosensitized tumors, active caspase-3 labeling prevailed in all cases. This observation was confirmed by the comparison of AIs averaged for each marker (Table 2) . Maximal staining (8.3 6 2.9%) was obtained for active caspase-3 and was found significantly different (p,0.02) from active caspase-7 (4.9 6 1.5%) and c-PARP (5.0 6 2.0%). Overlaid images taken from immunofluorescence experiments performed on a tissue section subjected successively to active caspase-3 and c-PARP in control ( Figure 6A ) or in Foscan-photosensitized tumors (Figure 6B ) provided additional information. In all labeled cells, c-PARP (shown in green) colocalized with active caspase-3 (shown in red), thus providing yellow spots. In some cases, tiny yellow spots were enclosed in red signals suggesting limited expression of c-PARP. This feature was predominantly observed in control tumors ( Figure 6A) . A careful examination of immunostained tissue sections ( Figures 6C and 6D) confirmed this observation. Many apoptotic cells from control tumors showed nuclei containing a limited part of labeled antigenic sites ( Figure 6C ), whereas photosensitized tumors showed a higher number of cells with a large expression of c-PARP ( Figure 6D ). These cells were noticed without apoptotic-related nuclear morphological change, suggesting that apoptosis in these cells was at an early stage.
Another observation from immunofluorescence analysis was the poor correlation between active caspase-3 (red) and active caspase-7 (green) in Foscanphotosensitized tumors (Figure 7) . Expression of active caspase-7 was not detectable in all active caspase-3expressing cells. As a result, some labeled cells exhibited only a red signal. Conversely, all cells detected by the antibody to active caspase-7 expressed active caspase-3 antigen, thus showing yellow spots.
Discussion
Two major apoptotic pathways, namely the extrinsic (through membrane death receptor) and intrinsic (through mitochondria), are governed by caspases, a Figure 5 Apoptotic index from active caspase-3, active caspase-7, or c-PARP staining applied on HT29 subcutaneous xenografts subjected to Foscan (0.3 mg/kg, IV) photosensitization (10 J/cm 2 , 30 mW/cm 2 , 24 hr after injection). Note the variability between tumors. AIs were determined from at least 2000 tumor cells in each section.
family of proteases that cleave substrates at Asp-Xxx sequence. Based on their function, caspases have been divided into initiators or executioners of apoptosis. The executioner class includes caspase-3, caspase-6, which is processed by caspase-3 (Slee et al. 2001) , and caspase-7. The precise role of caspase-7 during apoptosis remains elusive (Slee et al. 2001; Lakhani et al. 2006 ), whereas caspase-3 is generally considered to be the primary executioner of apoptosis. Therefore, the development of antibodies targeting either the active form of caspase-3 or cleaved substrates resulting from its activation warrants investigation (Holubec et al. 2005; Jakob et al. 2008) .
In this study, we proposed to extend the investigation to caspase-7 processing and PARP-1 cleavage. Caspases-3 and -7 have some overlapping but also some distinct roles in apoptosis. It has been shown that caspase-3 controls DNA fragmentation and morphological changes of apoptosis (Slee et al. 2001; Lakhani et al. 2006 ). Caspase-7 plays a little role in these processes but could be important in the loss of cellular viability (Lakhani et al. 2006) . In this context, PARP, which is generally recognized as a substrate of both caspases-3 and -7 with a strong affinity for the latter (Germain et al. 1999) , could be a very useful marker of apoptosis. We performed an IHC study of apoptosis Figure 6 Merging of immunofluorescence images obtained from control tumors (A) or Foscan (0.3 mg/kg, IV)-photosensitized (10 J/cm 2 , 30 mW/cm 2 ) HT29 subcutaneous xenografts (B) frozen 24 hr after treatment. Frozen sections were first subjected to active caspase-3 (red fluorescence) and then to c-PARP (green fluorescence). Colocalization between both markers showed large yellow spots (thick white arrows) or tiny yellow spots (thin white arrows) caused by c-PARP expression. c-PARP IHC on paraffin sections of control tumors (C) and photosensitized tumors (D). Thin black arrows indicate limited expression of c-PARP, whereas the thick black arrow indicates a large expression of c-PARP in nuclei of apoptotic cells.
at three different levels of preclinical models, monolayer cells from three cell lines (HT29, KB, and MDA-MB231), HT29 cell spheroids that mimic avascular microtumors, and HT29 tumors xenografted in nude mice. Apoptotic cells at the late stage of the process showed morphological criteria (chromatin condensation with a marked accumulation of densely stained chromatin at the edge of the nucleus and cell fragmentation with formation of apoptotic bodies) that enabled their identification by standard hematoxylin and eosin staining. However, in paclitaxel-treated cells, abnormal mitotic figures resembling those of apoptosis could be confusing ( Figure 1A) . Active caspase-3 immunostaining was confirmed as a highly sensitive method that could clearly show the different steps in the location of caspase-3 activation from cytoplasmic to nuclear translocation of the protein ( Figure 1B ). This latter feature was not observed with active caspase-7 ( Figure 1C ), which does not translocate into the nucleus after induction of apoptosis (Kamada et al. 2005) , thus supporting the difference between the two caspases in their respective role in the nuclear mor-phological changes during apoptosis. c-PARP labeling in the whole area of apoptotic nuclei ( Figure 1C ) was anticipated because PARP-1 is a DNA-binding enzyme that signals DNA strand breaks. Moreover, we applied an antibody to the large 85-kDa fragment of c-PARP, which has been shown to be translocated from the nucleolus to the nucleoplasm during apoptosis, whereas the short 29-kDa fragment is retained in nucleoli (Alvarez-Gonzalez et al. 1999) . Compared with active caspase-3 or -7 labeling, the use of the antibody to c-PARP resulted in a poor staining of cells undergoing physiological apoptosis in control samples or in apoptosis-resistant MDA-MB231 cells treated with paclitaxel (Figure 3; Tables 1 and 2 ). Further analysis performed by merging the immunofluorescence images indicated a high level of colocalization between active caspase-3 and c-PARP in HT29 tumors ( Figures 6A  and 6B) . A similar observation has been earlier reported in medulloblastomas (Puig et al. 2001 ). However, immunofluorescence from c-PARP labeling was restricted to tiny spots ( Figure 7A ), indicating a limited expression of the protein that could explain the difficulty to detect the cleaved form of PARP by enzymatic IHC. After treatment in vitro of HT29 or KB cells either by paclitaxel or by Foscan-PDT, the pattern of c-PARP labeling was close to those of active caspases-3 and -7 ( Figures 3A, 3B, and 4) . Likewise, in Foscanphotosensitized MDA-MB231, IHC to c-PARP and active caspase-7 resulted in a non-significantly different AI values ( Figure 3C ). These results suggest that cell damage either increased the number of antigenic sites and/or modified the extend of expression of c-PARP large fragments over the nucleus. In fact, both events could be related to the overactivation of full-length PARP-1 shortly before or simultaneously to the cleavage of PARP by caspases (Germain et al. 1999; Simbulan-Rosenthal et al. 1999; D'Amours et al. 2001) . It has been recently reported that the nucleolus serves as a storage supplying PARP-1 in response to heavy DNA damage (Mortusewicz et al. 2007 ). Thus, the translocation of 85-kDa PARP fragments from the nucleolus to the nucleoplasm could occurs along with covalently bound poly(ADP-ribose) generated by the poly(ADP-ribosyl)ation catalyzed by the massive recruitment of PARP-1 from nucleoli to damage sites (Alvarez-Gonzalez et al. 1999) . Taken together, these observations could imply a close relationship between the activity of PARP poly(ADP-ribosyl)ation, the amount of antigenic sites and the distribution of cleaved fragments over the nucleus after treatment. In this context, the percentage of c-PARP-labeled cells (5.0 6 2.0%; Table 2 ) in Foscan-photosensitized HT29 tumors could represent an accurate evaluation of photoinduced apoptosis, whereas apoptotic assessment through caspases-3 or -7 activation includes both basic physiological and treatment-induced apoptosis. Figure 7 Merging of immunofluorescence images obtained from Foscan (0.3 mg/kg, IV)-photosensitized (10 J/cm 2 , 30 mW/cm 2 ) HT29 subcutaneous xenografts frozen 24 hr after treatment. Frozen sections were first subjected to active caspase-3 (red fluorescence) and then to active caspase-7 (green fluorescence). Colocalization between both markers showed yellow spots (thick arrows). Red spots (thin arrows) indicate active caspase-3 expression only.
Both treatments, paclitaxel and Foscan-PDT, trigger apoptosis in cells by the activation of caspases-3 and -7 (Goncalves et al. 2000; Kottke et al. 2002; Marchal et al. 2005) . Caspase-7 has been recently presumed to play a major role in the induction of apoptosis under severe oxidative stress of the endoplasmic reticulum (Reddy et al. 2003; Rao et al. 2004 ). This molecular pathway has been strongly suggested after Foscan-PDT in the mammary adenocarcinoma MCF-7 cell line that lacks caspase-3 (Marchal et al. 2007 ). IHC to active caspase-3 and active caspase-7 applied on HT29 and KB monolayer cells and HT29 spheroids treated by either paclitaxel or Foscan-PDT showed a close percentage of cells expressing caspase-3 or caspase-7 activation ( Figures 3A and 3B ; Table 1 ). Thus, equal involvement of both caspases in the apoptotic pathway may be presumed. On the other hand, in Foscanphotosensitized MDA-MB231 cells ( Figure 3C ) or HT29 tumors (Table 2) , active caspase-3 labeling was predominant. Colocalization obtained from merged immunofluorescence images indicated that active caspase-7 was not expressed in all caspase-3-expressing cells (Figure 7 ), suggesting that Foscan-PDT-induced apoptosis was mainly processed through the activation of caspase-3 in HT29 tumors. Likewise, MDA-MB231 monolayer cells could be more susceptible to caspase-3 activation after Foscan-PDT than HT29 and KB cell lines.
In conclusion, the use of c-PARP as a marker of physiological apoptosis is doubtful, whereas it could be a useful indicator of treatment-induced apoptosis probably by DNA damage. The biological significance in the different pattern of expression of active caspase-3 and -7 in Foscan-photosensitized tumors needs further study. As a general rule, the use of different antibodies to differentiate caspase-dependent apoptotic pathways in vivo is relevant.
